Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization

被引:6
|
作者
Lu, Jun Ling [1 ]
Molnar, Miklos Z. [1 ,2 ]
Sumida, Keiichi [1 ,3 ,4 ]
Diskin, Charles D. [5 ]
Streja, Elan [6 ]
Siddiqui, Omer A. [1 ]
Kalantar-Zadeh, Kamyar [6 ]
Kovesdy, Csaba P. [1 ,7 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[2] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[3] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan
[4] Univ Tsukuba, Fac Med, Dept Nephrol, Ibaraki, Japan
[5] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[6] Univ Calif Irvine, Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Div Nephrol & Hypertens, Orange, CA USA
[7] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN 38104 USA
关键词
chronic kidney disease; end-stage renal disease; hospitalization; mortality; pre-ESRD laboratory testing; CHRONIC KIDNEY-DISEASE; PREDIALYSIS NEPHROLOGY CARE; GLOMERULAR-FILTRATION-RATE; SERUM POTASSIUM; OUTCOMES; MANAGEMENT; SURVIVAL; DIALYSIS; ANEMIA; INITIATION;
D O I
10.1093/ndt/gfx192
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Previous studies have demonstrated that early pre-end-stage renal disease (ESRD) nephrology care could improve postdialysis prognosis. However, less is known about the specific types of interventions responsible for the improved outcomes. We hypothesized that more frequent predialysis laboratory testing is associated with better postdialysis outcomes in incident ESRD patients. Methods. In all, 23 089 patients with available outpatient laboratory tests performed during the 2-year predialysis (i.e. prelude) period were identified from a total of 52 172 American veterans with chronic kidney disease (CKD) transitioning to dialysis between October 2007 and September 2011. The associations between the frequency of combined laboratory tests, including serum creatinine, serum potassium and hemoglobin (test trio), with postdialysis mortality and hospitalization were examined in multivariable adjusted Cox and logistic regression models. Results. When entering the 2-year prelude period, the mean age (Standard Deviation) of the patients was 66.2 (SD 11.3) years and the mean estimated glomerular filtration rate was 46.8 (SD 23.9) mL/min/1.73 m(2). In all, 14% of patients had the test trio performed less than twice in 24 months and 8.9% had the trio measured more often than every other month. Over a 2.5-year median postdialysis follow-up period, 15 303 (66.3%) patients died (mortality rate 260/1000 patient-years). The adjusted hazard ratio of all-cause mortality and adjusted odds ratio of the composite of hospitalization or death associated with lab testing done >12/24 months compared with 2-<= 4/24 months were 0.68 [95% confidence interval (CI) 0.65-0.73] and 0.70 (95% CI 0.62-0.79), respectively. Conclusions. More frequent laboratory testing in patients with advanced CKD is associated with better clinical outcomes after dialysis. Further examination in clinical trials is needed before the implementation of more frequent laboratory testing in clinical practice.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [41] END STAGE RENAL-DISEASE
    ANDERSEN, RC
    MINNESOTA MEDICINE, 1975, 58 (02) : 195 - 195
  • [42] Hyperhomocysteinaemia and end stage renal disease
    Gupta, A
    Robinson, K
    JOURNAL OF NEPHROLOGY, 1997, 10 (02) : 77 - 84
  • [43] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [44] Frequency of Ischemic Heart Disease in Patients of End Stage Renal Disease
    Akhtar, Muhammad Farhan
    Siddque, Hafiz Muhammad Waqas
    Nazir, Talha
    Khan, Ubaid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (07): : 2059 - 2061
  • [45] End stage renal disease and medicare
    Greer, JW
    HEALTH CARE FINANCING REVIEW, 2003, 24 (04): : 1 - 5
  • [46] ANXIETY IN END STAGE RENAL DISEASE
    Cukor, Daniel
    Safier, Michal
    Mitra, Angeliqua
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S101 - S101
  • [47] Efavirenz in end stage renal disease
    Prime, KP
    Jungmann, EMA
    Pakianathan, MR
    Woolfson, I
    AIDS, 2000, 14 : S23 - S24
  • [48] Pregnancy in End Stage Renal Disease
    Hladunewich, Michelle
    Hercz, Adam Engel
    Keunen, Johannes
    Chan, Christopher
    Pierratos, Andreas
    SEMINARS IN DIALYSIS, 2011, 24 (06) : 634 - 639
  • [49] END STAGE RENAL-DISEASE
    BRUNNER, F
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1981, 70 (19): : 835 - 837
  • [50] Hospitalization in the first year of renal replacement therapy for end-stage renal disease
    Metcalfe, W
    Khan, IH
    Prescott, GJ
    Simpson, K
    MacLeod, AM
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (12) : 899 - 909